[Expression and clinical significance of VEGF and its receptors Flt-1 and KDR in nasopharyngeal carcinoma]

Ai Zheng. 2006 Feb;25(2):229-34.
[Article in Chinese]

Abstract

Background & objective: Vascular endothelial growth factor (VEGF) and its receptors fms-like tyrosine kinase-1 (Flt-1) and kinase insert domain containing receptor (KDR) play critical roles in angiogenesis and tumor progression. This study was to explore the correlations of VEGF, Flt-1 and KDR expression to clinical features and prognosis of nasopharyngeal carcinoma (NPC) patients.

Methods: Immunohistochemistry was adopted to detect the expression of VEGF, Flt-1, and KDR in 127 specimens of NPC. SPSS statistical software was used to analyze their correlations to clinical features and prognosis of NPC patients.

Results: The positive rates of VEGF,Flt-1,and KDR were 66.9%, 90.6%, and 88.2% in the NPC specimens. The expression of VEGF was positively related to the expression of Flt-1 and KDR (r=0.292, P<0.01; r=0.287, P<0.01). The expression of Flt-1 was positively related to the expression of KDR (r=0.723, P<0.01). VEGF expression was related to primary tumor site, lymph node metastasis, and clinical stage (P=0.04, P<0.01, P=0.02, respectively); KDR expression was related to primary tumor site (P=0.03); all of them were related to local recurrence and/or distal metastasis (P<0.01, P<0.01, P=0.01, respectively), and poor overall survival (P<0.01, P=0.01, P=0.03, respectively). Cox multivariate analysis showed age of more than 50 years and positive VEGF expression were independent prognostic factors (P<0.01, P<0.01).

Conclusion: VEGF, Flt-1, and KDR are widely expressed in NPC tissues, and are positively related to clinical features and prognosis of NPC patients.

Publication types

  • English Abstract

MeSH terms

  • Adolescent
  • Adult
  • Age Factors
  • Aged
  • Bone Neoplasms / metabolism
  • Bone Neoplasms / secondary
  • Carcinoma, Squamous Cell / metabolism*
  • Carcinoma, Squamous Cell / pathology
  • Carcinoma, Squamous Cell / radiotherapy
  • Female
  • Follow-Up Studies
  • Humans
  • Liver Neoplasms / metabolism
  • Liver Neoplasms / secondary
  • Lymphatic Metastasis
  • Male
  • Middle Aged
  • Nasopharyngeal Neoplasms / metabolism*
  • Nasopharyngeal Neoplasms / pathology
  • Nasopharyngeal Neoplasms / radiotherapy
  • Neoplasm Recurrence, Local
  • Neoplasm Staging
  • Prognosis
  • Proportional Hazards Models
  • Survival Rate
  • Vascular Endothelial Growth Factor A / metabolism*
  • Vascular Endothelial Growth Factor Receptor-1 / metabolism*
  • Vascular Endothelial Growth Factor Receptor-2 / metabolism*

Substances

  • Vascular Endothelial Growth Factor A
  • Vascular Endothelial Growth Factor Receptor-1
  • Vascular Endothelial Growth Factor Receptor-2